Geraldine Bliss wants parents to ask, “Could it be genetic?”
One genetic test changed everything for her son. Now Bliss, the founder of Start Genetic, wants more families to get answers sooner.
One genetic test changed everything for her son. Now Bliss, the founder of Start Genetic, wants more families to get answers sooner.
Across China, Illumina is delivering end-to-end research analysis support, scalable high-performance computing, and localized deployment
How CEO Jacob Thaysen’s journey was shaped by a drive to transform health—and how Illumina is redefining genomics workflows
At ESHG, the Exeter professor discusses her genomics career and talks about the future of whole-genome sequencing
Proteomics reveals how proteins drive biology—helping researchers understand disease, uncover biomarkers, and advance precision medicine
| Date | Publication | Title |
|---|---|---|
| Jun 23, 2025 | Endpoints News | Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics |
| Jun 17, 2025 | Forbes | Illumina’s New CIO Brings R&D Mindset As AI Transforms Genomics |
| Jun 13, 2025 | GEN | Proteomics Partnerships Move Multiomics from Theory to Practice |
| Jun 13, 2025 | GEN | Silver Anniversary of the Human Genome Project |
| Jun 12, 2025 | Colorado State University | The pathogen hunter: Next-Generation Sequencing tracks down genetic mutations |

At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.